Increased cyclic adenosine 3',5'-monophosphate content in guinea pig ileum after exposure to Staphylococcus aureus delta-toxin.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMC 420590)

Published in Infect Immun on January 01, 1976

Authors

A D O'Brien, F A Kapral

Articles cited by this

A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A (1970) 23.79

A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera. Nature (1965) 16.86

Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli. Infect Immun (1974) 12.51

Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99

Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nat New Biol (1972) 6.65

Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J Clin Invest (1971) 6.09

Induction of steroidogenesis in tissue culture by cholera enterotoxin. Nat New Biol (1973) 4.72

Classification of enterotoxins on the basis of activity in cell culture. J Infect Dis (1975) 4.52

Stimulation of intestinal adenyl cyclase by cholera toxin. Nature (1971) 4.27

Stimulation of steroidogenesis in tissue culture by enterotoxigenic Escherichia coli and its neutralization by specific antiserum. Infect Immun (1974) 4.19

Product of Staphylococcus aureus responsible for the scalded-skin syndrome. Infect Immun (1971) 4.19

The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. J Clin Invest (1972) 4.05

Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest (1972) 3.28

Purification and properties of staphylococcal delta hemolysin. Infect Immun (1971) 3.19

Purification and biochemical properties of Clostridium perfringens type A enterotoxin. Infect Immun (1972) 2.89

Quantitative microassay in cell culture for enterotoxin of Shigella dysenteriae. J Infect Dis (1972) 2.40

Stimulation of glycerol production in fat cells by cholera toxin. Nature (1970) 2.34

Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin. J Clin Invest (1974) 1.89

Cholera and other enterotoxin-related diarrheal diseases. J Infect Dis (1972) 1.79

Pathogenesis of bacterial diarrheas. I. N Engl J Med (1971) 1.71

In Vivo Effects of Clostridium perfringens Enteropathogenic Factors on the Rat Ileum. Infect Immun (1974) 1.59

Inhibition of Staphylococcus aureus delta hemolysin by phospholipids. Proc Soc Exp Biol Med (1972) 1.49

Effects of staphylococcal enterotoxin B on intestinal transport in the rat. Am J Physiol (1971) 1.45

Production of thermostable hemolysin by cultures of Staphylococcus epidermidis. J Infect Dis (1968) 1.42

Comparison of secretory and histological effects of shigella and cholera enterotoxins in rabbit jejunum. Gastroenterology (1975) 1.35

Studies on the cell toxicity and species specificity of purified staphylococcal toxins. Acta Pathol Microbiol Scand (1967) 1.20

The pathophysiology of cholera. Bull N Y Acad Med (1971) 1.20

Inhibition of water absorption in the intestine by Staphylococcus aureus delta-toxin. Infect Immun (1976) 1.05

Antistaphylococcal hemolysins and delta hemolysin inhibitor in adult human serum. Can J Microbiol (1969) 1.04

Characterization and partial purification of staphylococcal delta-lysin. Acta Pathol Microbiol Scand (1968) 1.01

Properties of adenyl cyclase from human jejunal mucosa during naturally acquired cholera and convalescence. J Clin Invest (1972) 1.01

Comparison of the effects of enterotoxins of Shigella dysenteriae and Vibrio cholerae on the adenylate cyclase system of the rabbit intestine. J Infect Dis (1974) 0.97

SOME OBSERVATIONS ON THE PATHOGENESIS OF CHOLERA. Indian J Med Res (1964) 0.87

Ion transport across intestinal mucosa of winter flounder, Pseudopleuronectes americanus. Am J Physiol (1971) 0.80

Articles by these authors

(truncated to the top 100)

The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis (1985) 9.18

Shiga and Shiga-like toxins. Microbiol Rev (1987) 8.58

Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun (1986) 8.09

Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis (1982) 8.05

Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science (1984) 7.94

Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine. J Bacteriol (1988) 5.43

Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J Immunol (1983) 5.22

Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect Immun (1985) 5.04

Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect Immun (1991) 4.63

Product of Staphylococcus aureus responsible for the scalded-skin syndrome. Infect Immun (1971) 4.19

The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest (1993) 4.11

Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol (1988) 3.98

Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun (1987) 3.96

Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect Immun (1983) 3.85

A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun (1987) 3.76

Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli. Science (1985) 3.66

Production of Shiga-like toxin by Escherichia coli. J Infect Dis (1986) 3.53

Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun (1993) 3.36

Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol (1980) 3.31

Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb Pathog (1987) 3.25

Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. Lancet (1984) 3.05

Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun (1990) 3.02

Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun (1990) 3.00

Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect Immun (1977) 2.94

Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun (1980) 2.82

Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay. J Clin Microbiol (1988) 2.76

Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun (1995) 2.69

Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest (2001) 2.67

The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol Microbiol (1991) 2.54

Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins. Infect Immun (1982) 2.50

Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun (1993) 2.38

Absence of all components of the flagellar export and synthesis machinery differentially alters virulence of Salmonella enterica serovar Typhimurium in models of typhoid fever, survival in macrophages, tissue culture invasiveness, and calf enterocolitis. Infect Immun (2001) 2.38

Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves. Infect Immun (1998) 2.37

Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun (1990) 2.32

Are the Lsh and Ity disease resistance genes at one locus on mouse chromosome 1? Nature (1982) 2.29

Flagella of Salmonella typhimurium are a virulence factor in infected C57BL/6J mice. Infect Immun (1984) 2.15

Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem (1989) 2.12

Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers. Proc Natl Acad Sci U S A (1994) 2.11

Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect Immun (1996) 2.04

Flagella help Salmonella typhimurium survive within murine macrophages. Infect Immun (1984) 1.95

Genetic control of resistance to infection in mice. Crit Rev Immunol (1982) 1.93

Shiga-like toxin production from Escherichia coli associated with calf diarrhoea. Vet Rec (1985) 1.91

Effect of silica on the innate resistance of inbred mice to Salmonella typhimurium infection. Infect Immun (1979) 1.91

Control of early Salmonella typhimurium growth in innately Salmonella-resistant mice does not require functional T lymphocytes. J Immunol (1982) 1.90

Susceptibility of CBA/N mice to infection with Salmonella typhimurium: influence of the X-linked gene controlling B lymphocyte function. J Immunol (1979) 1.90

Purification of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis. Lancet (1983) 1.87

A BALB/c congenic strain of mice that carries a genetic locus (Ityr) controlling resistance to intracellular parasites. Infect Immun (1983) 1.86

Cellular release of heat-labile enterotoxin of Escherichia coli by bacteriophage induction. Infect Immun (1978) 1.85

Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci. Nature (1980) 1.83

Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb Pathog (1989) 1.78

Shiga-like toxin production and attaching effacing activity of Escherichia coli associated with calf diarrhea. Am J Vet Res (1987) 1.75

Genetically conferred defect in anti-Salmonella antibody formation renders CBA/N mice innately susceptible to Salmonella typhimurium infection. J Immunol (1981) 1.75

Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis (1991) 1.73

Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine. Am J Pathol (1986) 1.72

The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect Immun (1994) 1.70

In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity. Infect Immun (1989) 1.69

Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli. Infect Immun (2001) 1.64

A Salmonella typhimurium virulence gene linked to flg. Infect Immun (1989) 1.64

Escherichia coli O157:H7 in beef cattle presented for slaughter in the U.S.: higher prevalence rates than previously estimated. Proc Natl Acad Sci U S A (2000) 1.58

Truncated enterohemorrhagic Escherichia coli (EHEC) O157:H7 intimin (EaeA) fusion proteins promote adherence of EHEC strains to HEp-2 cells. Infect Immun (1996) 1.56

Adherence and colonization mechanisms of enteropathogenic and enterohemorrhagic Escherichia coli. Microb Pathog (1992) 1.55

Staphylococcus aureus: some host-parasite interactions. Ann N Y Acad Sci (1974) 1.53

Mutation of flgM attenuates virulence of Salmonella typhimurium, and mutation of fliA represses the attenuated phenotype. J Bacteriol (1994) 1.51

Inhibition of Staphylococcus aureus delta hemolysin by phospholipids. Proc Soc Exp Biol Med (1972) 1.49

Investigation of enterohemorrhagic Escherichia coli O157:H7 adherence characteristics and invasion potential reveals a new attachment pattern shared by intestinal E. coli. Infect Immun (1995) 1.45

Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism. Infect Immun (2000) 1.40

Effects of iron and temperature on Shiga-like toxin I production by Escherichia coli. Infect Immun (1988) 1.40

Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli. J Bacteriol (1990) 1.39

An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun (1992) 1.39

Flagellar phase variation of Salmonella enterica serovar Typhimurium contributes to virulence in the murine typhoid infection model but does not influence Salmonella-induced enteropathogenesis. Infect Immun (2001) 1.37

Genetic control of the innate resistance of mice to Salmonella typhimurium: Ity gene is expressed in vivo by 24 hours after infection. J Immunol (1983) 1.37

Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infect Immun (1996) 1.37

Innate resistance of mice to Salmonella typhi infection. Infect Immun (1982) 1.34

Clumping of Staphylococcus aureus in the peritoneal cavity of mice. J Bacteriol (1966) 1.30

Influence of host genes on resistance of inbred mice to lethal infection with Salmonella typhimurium. Curr Top Microbiol Immunol (1986) 1.29

Defect in macrophage effector function confers Salmonella typhimurium susceptibility on C3H/HeJ mice. Cell Immunol (1982) 1.28

Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. J Bacteriol (1990) 1.24

Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin. Infect Immun (1999) 1.24

Genetic control of the susceptibility of C3HeB/FeJ mice to Salmonella typhimurium is regulated by a locus distinct from known salmonella response genes. J Immunol (1983) 1.23

Silica enhancement of murine endotoxin sensitivity. Infect Immun (1982) 1.22

Mouse chromosome 1 Ity locus regulates microbicidal activity of isolated peritoneal macrophages against a diverse group of intracellular and extracellular bacteria. J Immunol (1985) 1.22

Position on mouse chromosome 1 of a gene that controls resistance to Salmonella typhimurium. Infect Immun (1982) 1.22

Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J Biol Chem (2000) 1.21

Virulence of Shiga toxin-producing Escherichia coli (STEC) in orally-infected mice correlates with the type of toxin produced by the infecting strain. Jpn J Med Sci Biol (1998) 1.20

Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect Immun (2001) 1.18

Bacterial toxins: friends or foes? Emerg Infect Dis (1999) 1.18

Characterization of murine antibody response to Salmonella typhimurium by a class-specific solid-phase radioimmunoassay. Infect Immun (1981) 1.18

The attenuated phenotype of a Salmonella typhimurium flgM mutant is related to expression of FliC flagellin. J Bacteriol (1996) 1.18

Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in Staphylococcus aureus 18Z. Infect Immun (1991) 1.16

Production of a unique cytotoxin by Campylobacter jejuni. Infect Immun (1987) 1.16

Pulmonary infection of mice with Staphylococcus aureus. Infect Immun (1978) 1.14

Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HeJ mice. Cell Immunol (1986) 1.13

Escherichia coli O157:H7 causes more-severe systemic disease in suckling piglets than in colostrum-deprived neonatal piglets. Infect Immun (2000) 1.13

Characterization of a bactericidal lipid developing within staphylococcal abscesses. Infect Immun (1981) 1.11

Role of diminished epithelial GM-CSF in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2000) 1.10

Factors involved in experimental staphylococcal peritonitis. Ann N Y Acad Sci (1965) 1.10

Epidermal toxin production by Staphylococcus aureus strains from patients with toxic shock syndrome. Ann Intern Med (1982) 1.08

Partial characterization of a bactericidal system in staphylococcal abscesses. Infect Immun (1980) 1.08

Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity. J Bacteriol (1991) 1.07

Formation of intraperitoneal abscesses by Staphylococcus aureus. Infect Immun (1980) 1.07